Correction to: Stanniocalcin-1 Inhibits Renal Ischemia/Reperfusion Injury via an AMP-Activated Protein Kinase-Dependent Pathway
Journal of the American Society of Nephrology · 18.11.2026
DOI: 10.1681/asn.0000001341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 18.11.2026. Verfasst von Jenny Szu-Chin Pan und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pan, J. S., Huang, L., Belousova, T., Lu, L., Yang, Y., Reddel, R., Chang, A., Ju, H., DiMattia, G., Tong, Q., & Sheikh-Hamad, D. (2026). Correction to: Stanniocalcin-1 Inhibits Renal Ischemia/Reperfusion Injury via an AMP-Activated Protein Kinase-Dependent Pathway. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001341
Vancouver
Pan JS, Huang L, Belousova T, Lu L, Yang Y, Reddel R, et al. Correction to: Stanniocalcin-1 Inhibits Renal Ischemia/Reperfusion Injury via an AMP-Activated Protein Kinase-Dependent Pathway. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001341
BibTeX
@article{Pan2026,
author = {Pan, Jenny Szu-Chin and Huang, Luping and Belousova, Tatiana and Lu, Lianghao and Yang, Yongjie and Reddel, Roger and Chang, Andy and Ju, Huiming and DiMattia, Gabriel and Tong, Qiang and Sheikh-Hamad, David},
title = {Correction to: Stanniocalcin-1 Inhibits Renal Ischemia/Reperfusion Injury via an AMP-Activated Protein Kinase-Dependent Pathway},
journal = {Journal of the American Society of Nephrology},
year = {2026},
doi = {10.1681/asn.0000001341}
}
EUVIMED